Cargando…

Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization

Glycero- and sphingo-lipids are important in plasma membrane structure, caloric storage and signaling. An un-targeted lipidomics approach for a cohort of critically ill pediatric intensive care unit (PICU) patients undergoing multi-organ dysfunction syndrome (MODS) was compared to sedation controls....

Descripción completa

Detalles Bibliográficos
Autores principales: Leimanis-Laurens, Mara, Wolfrum, Emily, Ferguson, Karen, Grunwell, Jocelyn R., Sanfilippo, Dominic, Prokop, Jeremy W., Lydic, Todd A., Rajasekaran, Surender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145972/
https://www.ncbi.nlm.nih.gov/pubmed/33923179
http://dx.doi.org/10.3390/jpm11050339
_version_ 1783697292270764032
author Leimanis-Laurens, Mara
Wolfrum, Emily
Ferguson, Karen
Grunwell, Jocelyn R.
Sanfilippo, Dominic
Prokop, Jeremy W.
Lydic, Todd A.
Rajasekaran, Surender
author_facet Leimanis-Laurens, Mara
Wolfrum, Emily
Ferguson, Karen
Grunwell, Jocelyn R.
Sanfilippo, Dominic
Prokop, Jeremy W.
Lydic, Todd A.
Rajasekaran, Surender
author_sort Leimanis-Laurens, Mara
collection PubMed
description Glycero- and sphingo-lipids are important in plasma membrane structure, caloric storage and signaling. An un-targeted lipidomics approach for a cohort of critically ill pediatric intensive care unit (PICU) patients undergoing multi-organ dysfunction syndrome (MODS) was compared to sedation controls. After IRB approval, patients meeting the criteria for MODS were screened, consented (n = 24), and blood samples were collected from the PICU at HDVCH, Michigan; eight patients needed veno-arterial extracorporeal membrane oxygenation (VA ECMO). Sedation controls were presenting for routine sedation (n = 4). Plasma lipid profiles were determined by nano-electrospray (nESI) direct infusion high resolution/accurate mass spectrometry (MS) and tandem mass spectrometry (MS/MS). Biostatistics analysis was performed using R v 3.6.0. Sixty-one patient samples over three time points revealed a ceramide metabolite, hexosylceramide (Hex-Cer) was high across all time points (mean 1.63–3.19%; vs. controls 0.22%). Fourteen species statistically differentiated from sedation controls (p-value ≤ 0.05); sphingomyelin (SM) [SM(d18:1/23:0), SM(d18:1/22:0), SM(d18:1/23:1), SM(d18:1/21:0), SM(d18:1/24:0)]; and glycerophosphotidylcholine (GPC) [GPC(36:01), GPC(18:00), GPC(O:34:02), GPC(18:02), GPC(38:05), GPC(O:34:03), GPC(16:00), GPC(40:05), GPC(O:36:03)]. Hex-Cer has been shown to be involved in viral infection and may be at play during acute illness. GPC(36:01) was elevated in all MODS patients at all time points and is associated with inflammation and brain injury.
format Online
Article
Text
id pubmed-8145972
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81459722021-05-26 Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization Leimanis-Laurens, Mara Wolfrum, Emily Ferguson, Karen Grunwell, Jocelyn R. Sanfilippo, Dominic Prokop, Jeremy W. Lydic, Todd A. Rajasekaran, Surender J Pers Med Article Glycero- and sphingo-lipids are important in plasma membrane structure, caloric storage and signaling. An un-targeted lipidomics approach for a cohort of critically ill pediatric intensive care unit (PICU) patients undergoing multi-organ dysfunction syndrome (MODS) was compared to sedation controls. After IRB approval, patients meeting the criteria for MODS were screened, consented (n = 24), and blood samples were collected from the PICU at HDVCH, Michigan; eight patients needed veno-arterial extracorporeal membrane oxygenation (VA ECMO). Sedation controls were presenting for routine sedation (n = 4). Plasma lipid profiles were determined by nano-electrospray (nESI) direct infusion high resolution/accurate mass spectrometry (MS) and tandem mass spectrometry (MS/MS). Biostatistics analysis was performed using R v 3.6.0. Sixty-one patient samples over three time points revealed a ceramide metabolite, hexosylceramide (Hex-Cer) was high across all time points (mean 1.63–3.19%; vs. controls 0.22%). Fourteen species statistically differentiated from sedation controls (p-value ≤ 0.05); sphingomyelin (SM) [SM(d18:1/23:0), SM(d18:1/22:0), SM(d18:1/23:1), SM(d18:1/21:0), SM(d18:1/24:0)]; and glycerophosphotidylcholine (GPC) [GPC(36:01), GPC(18:00), GPC(O:34:02), GPC(18:02), GPC(38:05), GPC(O:34:03), GPC(16:00), GPC(40:05), GPC(O:36:03)]. Hex-Cer has been shown to be involved in viral infection and may be at play during acute illness. GPC(36:01) was elevated in all MODS patients at all time points and is associated with inflammation and brain injury. MDPI 2021-04-24 /pmc/articles/PMC8145972/ /pubmed/33923179 http://dx.doi.org/10.3390/jpm11050339 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Leimanis-Laurens, Mara
Wolfrum, Emily
Ferguson, Karen
Grunwell, Jocelyn R.
Sanfilippo, Dominic
Prokop, Jeremy W.
Lydic, Todd A.
Rajasekaran, Surender
Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization
title Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization
title_full Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization
title_fullStr Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization
title_full_unstemmed Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization
title_short Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization
title_sort hexosylceramides and glycerophosphatidylcholine gpc(36:1) increase in multi-organ dysfunction syndrome patients with pediatric intensive care unit admission over 8-day hospitalization
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145972/
https://www.ncbi.nlm.nih.gov/pubmed/33923179
http://dx.doi.org/10.3390/jpm11050339
work_keys_str_mv AT leimanislaurensmara hexosylceramidesandglycerophosphatidylcholinegpc361increaseinmultiorgandysfunctionsyndromepatientswithpediatricintensivecareunitadmissionover8dayhospitalization
AT wolfrumemily hexosylceramidesandglycerophosphatidylcholinegpc361increaseinmultiorgandysfunctionsyndromepatientswithpediatricintensivecareunitadmissionover8dayhospitalization
AT fergusonkaren hexosylceramidesandglycerophosphatidylcholinegpc361increaseinmultiorgandysfunctionsyndromepatientswithpediatricintensivecareunitadmissionover8dayhospitalization
AT grunwelljocelynr hexosylceramidesandglycerophosphatidylcholinegpc361increaseinmultiorgandysfunctionsyndromepatientswithpediatricintensivecareunitadmissionover8dayhospitalization
AT sanfilippodominic hexosylceramidesandglycerophosphatidylcholinegpc361increaseinmultiorgandysfunctionsyndromepatientswithpediatricintensivecareunitadmissionover8dayhospitalization
AT prokopjeremyw hexosylceramidesandglycerophosphatidylcholinegpc361increaseinmultiorgandysfunctionsyndromepatientswithpediatricintensivecareunitadmissionover8dayhospitalization
AT lydictodda hexosylceramidesandglycerophosphatidylcholinegpc361increaseinmultiorgandysfunctionsyndromepatientswithpediatricintensivecareunitadmissionover8dayhospitalization
AT rajasekaransurender hexosylceramidesandglycerophosphatidylcholinegpc361increaseinmultiorgandysfunctionsyndromepatientswithpediatricintensivecareunitadmissionover8dayhospitalization